-
Start Preamble
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary & Alternative Medicine Special Emphasis Panel NCCAM SEP W-01.
Date: November 28, 2001.
Time: 8: am to 5 pm.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Lawrence R Haller, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Boulevard, Rm. 106, Bethesda, MD 20892-5495, (301) 402-9011, ih194t@nih.gov.
Start SignatureDated: October 23, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-27152 Filed 10-26-01; 8:45 am]
BILLING CODE 4140-01-M
Document Information
- Effective Date:
- 11/28/2001
- Published:
- 10/29/2001
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 01-27152
- Dates:
- November 28, 2001.
- Pages:
- 54530-54530 (1 pages)
- PDF File:
- 01-27152.pdf